The trial start in a new model of the import Dipterocarpus tuberculatus full vaccine and Japan next week.

When the clinical test (trial) in Japan of a new influenza vaccine would be started from next week on the seventh, Japan corporation of medicine manufacture major Novartis in Switzerland clarified it.

The cooperation of 320 people in total of 200 adults and 120 infant is received in a domestic hospital, the vaccine is inoculated, effectiveness and safety are confirmed, and it makes it to the data to receive the approval of Ministry of Health, Labour and Welfare.

Expectation that consequence's turning out becomes about December.

Because only domestic production's worth is insufficient the charge rate for a new Dipterocarpus tuberculatus full vaccine, Ministry of Health, Labour and Welfare is under discussion as for the import.

As for the import vaccine such as this company, because the domestic production vaccine and the element use the difference and immunity adjuvant that heightens an effect, the confirmation of safety etc. is needed domestically.


- Former article: Http://www.asahi.com/health/news/TKY200909070275.html

Japan is good country!
http://japan-power.net/
PLEASE come here!